EBRD engagement in global efforts to curb antimicrobial resistance

The EBRD, a multilateral development bank, has been working to address Antimicrobial Resistance (AMR) and proposes to increase its engagement with stakeholders and regions. AMR is primarily accelerated by misuse and overuse of antibiotics, development challenges, and anthropological disruptions. It impacts human, animal, plant, and ecosystem health, incurring economic costs in healthcare spending, lost productivity, and deteriorating food safety and security. AMR is disproportionately borne by low- and middle-income countries and war-torn territories. The Bank recognizes AMR as a significant challenge for its regions, addressing Sustainable Development Goals and countering environmental and sustainability risks.